ReviewFrontiers in pharmacology2025

Targeting γ-aminobutyric acid pathways in irritable bowel syndrome: bridging central nervous system, enteric dysfunction, and the microbiota-gut-brain axis.

Christian Lambiase et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.